Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI)

Thirumurthi Karthikeyan1, Mani Raja2, Devarajan Radha3

  • 1Department of Cardiology, Madras Medical College, Chennai, Tamilnadu, India.

Insights

Patients with more risk factors and elevated inflammatory markers face a higher risk of ST-elevation myocardial infarction (STEMI). Controlling modifiable factors like obesity and lifestyle choices can reduce STEMI burden.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Public Health

Background:

  • Coronary artery disease (CAD), particularly atherosclerosis, is a leading cause of mortality.
  • Atherosclerosis is linked to inflammatory processes within coronary vessels.
  • Acute coronary syndromes, like ST-elevation myocardial infarction (STEMI), are major manifestations of CAD.

Purpose of the Study:

  • To investigate the association between traditional risk factors and inflammatory markers in patients with STEMI.
  • To evaluate the role of these factors in the occurrence and complications of STEMI.

Main Methods:

  • A case-control study involving 100 STEMI patients and 100 matched controls.
  • Data collection included medical history of risk factors (smoking, hypertension, diabetes, etc.) and anthropometric measurements (BMI).
  • Analysis of inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP) and erythrocyte sedimentation rate (ESR), from blood samples.

Main Results:

  • STEMI patients exhibited a higher prevalence of risk factors like smoking, hypertension, diabetes, and increased BMI compared to controls.
  • Elevated levels of hs-CRP and ESR were significantly observed in STEMI cases.
  • Specific risk factor profiles were associated with different STEMI locations and increased complication rates.

Conclusions:

  • A higher burden of risk factors and elevated inflammatory markers are strongly associated with increased STEMI risk and complications.
  • Modifiable risk factors, including obesity and lifestyle choices, represent key targets for reducing the incidence and impact of STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
30
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
43
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
22